Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies (Q90557208)
Jump to navigation
Jump to search
scientific article published on 07 October 2019
Language | Label | Description | Also known as |
---|---|---|---|
English | Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies |
scientific article published on 07 October 2019 |
Statements
Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies (English)
Gustavo Luna
Peter Alping
Joachim Burman
Katharina Fink
Anna Fogdell-Hahn
Martin Gunnarsson
Jan Hillert
Annette Langer-Gould
Jan Lycke
Petra Nilsson
Jonatan Salzer
Anders Svenningsson
Magnus Vrethem
Tomas Olsson
Fredrik Piehl
Thomas Frisell
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference